Nirman Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-05-2024
- Paid Up Capital ₹ 0.10 M
as on 20-05-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Nirman Nutraceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Datta Joshi, Ranjit Patil, Prashant Chaure, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233MH2015PTC264751
- Company No.
264751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Buldhana, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nirman Nutraceuticals Private Limited offer?
Nirman Nutraceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Protein Powder, Whey Protein, Whey Protein Isolate.
Who are the key members and board of directors at Nirman Nutraceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanmati Jain  | Director | 22-May-2015 | Current |
| Rahul Rane | Director | 22-May-2015 | Current |
| Datta Joshi | Director | 22-May-2015 | Current |
| Ranjit Patil | Director | 22-May-2015 | Current |
| Prashant Chaure | Director | 22-May-2015 | Current |
Financial Performance and Corporate Structure Insights of Nirman Nutraceuticals.
Enhance accessibility to Nirman Nutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nirman Nutraceuticals?
Unlock access to Nirman Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pristyn Food Tech Private Limited
Active 3 months 14 daysRahul Rane and Sanmati Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nirman Nutraceuticals?
Unlock and access historical data on people associated with Nirman Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirman Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirman Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
